A peptide test is independent when the laboratory is a separate entity with no stake in the result, the sample is documented as coming from the lot being sold, the method can establish the claim made, and the report can be verified with the laboratory. A test missing any one is a supplier's assertion on a laboratory's letterhead.
- A test is independent only if the laboratory is a separate entity with nothing riding on the result; an in-house result is release testing, not independence.
- ISO/IEC 17025 accreditation carries a public scope listing the specific tests assessed; the scope, not the certificate, says whether peptide purity was covered.
- The sample must be documented as drawn from the lot sold; an upstream bulk certificate has no connection to a vial unless the chain is shown.
- Identity needs mass spectrometry, purity needs HPLC with stated conditions, quantity needs a method that measures peptide mass; no single method gives all three.
- A report is evidence only if the issuing laboratory will confirm it by report number and sample; otherwise it rests on the supplier's word.
The phrase and what it is meant to buy
Nearly every research peptide supplier now says its material is third-party or independently tested, and the phrase has been repeated until it carries almost no information. What a buyer wants it to mean is simple: somebody with no reason to flatter the material examined it and wrote down what they found. Whether a given supplier's testing delivers that depends on four things, and a badge on a product page reveals none of them. This page sets out the four, in the order a buyer can check them, and says what each one looks like when it is real and when it is not.
The frame comes from two places. The first is the pharmaceutical rule on relying on a supplier's certificate, 21 CFR 211.84, which allows a manufacturer to accept a supplier's test results in place of its own only after establishing the reliability of the supplier's analyses through appropriate validation, at appropriate intervals. That is a regulatory statement of the obvious: a certificate is worth what the process behind it is worth, and the process has to be checked. The second is ISO/IEC 17025, the international standard for the competence of testing laboratories, which is what an accreditation body assesses a laboratory against and which defines what it means for a laboratory to be able to stand behind a result.
Condition one: a laboratory with nothing riding on the answer
Independence begins with who signs the report. A laboratory owned by the supplier, staffed by the supplier, or paid by the supplier per favourable certificate is not independent, however good its instruments. Neither is a laboratory that is a separate company on paper but shares owners, premises or staff with the seller. The test for this condition is whether the laboratory would lose anything by reporting that a lot failed, and the honest answer for a supplier's in-house lab is that it would lose a sale.
Accreditation is the outside evidence that a laboratory is a laboratory. Under ISO/IEC 17025 an accreditation body assesses a laboratory's management system, its technical competence, the validity of its methods and the traceability of its measurements, and issues a scope of accreditation listing the specific tests and matrices it has been assessed for. A laboratory that is accredited for HPLC purity of synthetic peptides has been examined on exactly the test a buyer cares about. A laboratory whose accreditation covers water chemistry and nothing else has been examined on something else. The scope is public through the accreditation body and is the first document to read after the certificate.
None of this makes an in-house laboratory worthless. A supplier that runs its own HPLC on every lot and publishes the chromatogram has done more than most. It has simply not done independent testing, and the honest description of its result is release testing by the supplier. The word independent should be reserved for a report from a separate entity, and a buyer who sees it used for anything else has learned how the supplier uses words.
Condition two: a sample that came from the lot
A perfectly independent laboratory can test a perfectly irrelevant sample. The second condition is that the material tested is documented as coming from the lot being sold, and this is the condition suppliers most often leave unstated. Three questions settle it. Who drew the sample, from what, and when.
The strongest form is a sample drawn from finished, sealed vials of the fill lot, chosen by someone other than the person selling them, after filling and labelling. That sample is the same thing the buyer receives. A weaker but still honest form is a sample of the bulk lot drawn before filling, which establishes identity and purity of the material but says nothing about fill mass or anything that happened at filling. The weakest form, and a common one, is a certificate the supplier received from its own upstream manufacturer for the bulk, re-presented as testing of the supplier's lot. That certificate may be perfectly accurate about the bulk and still have no documented connection to the vial in the buyer's hand.
The document that establishes the chain is the sample record: what was sampled, by whom, on what date, from which lot and how many units, and how it reached the laboratory. A laboratory report that names the sample it received by a lot identifier that matches the vial label has closed that chain at the laboratory end. A supplier that can state how the sample got there has closed it at the other. The batch traceability guide covers what a lot identifier has to reach; this condition is the same requirement pointed at the test.
Condition three: a method that can establish the claim
The third condition is easy to state and routinely violated: the test performed must be capable of establishing the thing the certificate claims. Tested is not a method. A purity figure requires a separation, almost always reversed-phase HPLC with ultraviolet detection, and the figure is an area percentage at the wavelength used. An identity claim requires mass spectrometry, because a chromatogram shows that a lot is mostly one thing without showing what that thing is. A quantity claim requires a method that measures peptide mass, such as amino acid analysis or a validated assay against a reference, since neither HPLC nor mass spectrometry weighs anything.
| Claim on the certificate | Method that can establish it | Method that cannot, however often it is cited |
|---|---|---|
| Identity: this is the named peptide | Mass spectrometry, observed mass against the theoretical mass of the sequence; sequencing or tandem MS for higher confidence | HPLC alone; a matching retention time against a supplier's own standard |
| Purity: the fraction that is the main component | RP-HPLC with UV detection, stated wavelength, stated column and gradient, area percent | Mass spectrometry alone; a visual description of the powder |
| Quantity: how much peptide is in the vial | Amino acid analysis, nitrogen determination, or a validated quantitative assay; Karl Fischer for water; ion chromatography for counterion | HPLC area percent; the label claim; the gross fill weight |
| Sterility or endotoxin | Compendial sterility test; LAL or recombinant factor C endotoxin assay | Purity or identity results of any kind |
The regulatory text for this is the ICH guidance on validation of analytical procedures, Q2(R1), adopted by the FDA, and the FDA's own guidance on analytical procedures and methods validation. Both describe what a method must demonstrate before its results mean anything: specificity, accuracy, precision, linearity, range and robustness, each appropriate to the type of test. A laboratory that reports a purity figure has, if it is doing its job, validated that its method separates the peptide from its likely impurities at the wavelength used. A report that states the method allows a reader to judge that; one that states only a number does not.
Condition four: a report you can verify without the supplier
The last condition is that the report can be checked with the laboratory that issued it, without going through the supplier. A certificate is a piece of paper, and paper is easy. What makes it evidence is that the laboratory holds the original, that the original carries a report number and a sample identifier, and that the laboratory will confirm on request that a report with that number and those results was issued for that sample. Many accredited laboratories offer a verification route, whether a portal, a QR code that resolves on the laboratory's own domain, or simply an email address that answers.
What verification catches is alteration. A supplier who receives a report showing 94 percent purity and publishes one showing 99 percent has committed the fraud this whole discipline exists to make difficult, and the only defence against it is a reader who checks the number with the laboratory. What it also catches, more often, is misattribution: a genuine report for one lot presented alongside a different lot, or a report years old presented as current. Both are visible the moment the laboratory is asked which sample and which date the report belongs to.
The Verify a COA page describes how to run this check and what a laboratory's verification route looks like. The point for this page is narrower: a report that cannot be verified with its issuer is not independent evidence, whatever its letterhead says, because the only party vouching for it is the supplier who benefits from it.
Reading a supplier's claim against the four conditions
Put together, the four conditions turn a vague badge into a checklist a buyer can run from a product page and an email.
- Name the laboratory. If the certificate does not name its issuer, stop. If it does, find the laboratory's accreditation scope and confirm it covers the test.
- Trace the sample. Ask the supplier who drew the sample, from which lot and at what stage. Bulk before fill, or sealed vials after? A supplier that knows will say in a sentence.
- Match the method to the claim. Identity needs mass spectrometry; purity needs HPLC with its conditions stated; quantity needs a method that weighs peptide. A certificate that claims all three from one chromatogram has claimed two things it did not measure.
- Verify with the issuer. Use the laboratory's route to confirm the report number, sample and results. If there is no route, the report rests on the supplier's word.
A supplier that passes all four has done independent testing. One that passes three has done something useful and described it loosely. One that passes none has a badge. The purpose of the checklist is not to catch suppliers out, though it will. It is to let a laboratory buy on evidence rather than on adjectives, which is the only basis on which a research reagent can be bought at all.
When to test it yourself
Independent testing by a supplier's laboratory is evidence about the lot. It is not a substitute for a receiving check by the laboratory that will use the material, and there are four situations in which that check is worth the instrument time. A new supplier, before the first result depends on it. A new lot of a compound the laboratory has used before, when the certificate's figures differ from the last one. A high-value compound, where a wasted experiment costs more than a chromatogram. And any result that surprised you, before the reagent is ruled out as the cause.
A receiving check does not need to repeat the certificate. An identity confirmation by mass spectrometry, or an HPLC run compared against the certificate's chromatogram for retention time and peak shape, is enough to establish that the vial contains what the certificate describes, and a retained vial from the same lot gives the laboratory something to go back to later. What the check establishes is agreement with the certificate. Disagreement is a finding, not a verdict, and the next step belongs to the supplier.
How a supplier responds to a buyer's out-of-specification finding is the last test of its documentation. A supplier with records asks for the buyer's method and chromatogram, pulls the laboratory record for the lot, checks the reserve sample if one was kept, and either explains the difference or replaces the material. A supplier without records has only the certificate to point at, and pointing at a certificate the buyer has just contradicted is not an answer. Ask, before ordering, what happens when a result does not match. The reply tells you whether the testing was ever meant to be checked.
Where our documentation stands on the four
LabFirst publishes, for each lot with a completed report, the issuing laboratory's name, the report itself, and the laboratory's own verification route, so the first and fourth conditions can be checked without asking us. The sample stage for each report is stated on the record where known, and where a field is not yet verified it is shown as pending rather than filled in. The compliance page states what LabFirst is and is not, and the purity testing guide explains what each method on a certificate can and cannot see. We would rather a buyer run the checklist above against our records than take the word independent on trust, because trust is exactly what the word is meant to replace.
Testing establishes what a material is and how pure a lot is. It establishes nothing about what the material is for. FOR LABORATORY AND IN-VITRO RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION. Independent documentation exists so that a laboratory can confirm what it received, and for no other purpose.
Common questions
Is a supplier's in-house HPLC result independent testing?
What does ISO/IEC 17025 accreditation actually tell me about a testing laboratory?
Can one certificate establish identity, purity and quantity?
Why does the sample stage matter if the laboratory is independent?
How do I verify a certificate with the laboratory?
Sources
- ISO/IEC 17025:2017, General requirements for the competence of testing and calibration laboratories. The standard a laboratory is accredited against; the basis for the scope-of-accreditation check in condition one.
- 21 CFR 211.84, Testing and approval or rejection of components, drug product containers, and closures. The regulatory rule that a supplier's certificate may be relied on only after the supplier's analyses have been validated; the frame for the whole page.
- FDA / ICH Q2(R1), Validation of Analytical Procedures: Text and Methodology. What an analytical method must demonstrate before its results mean anything: specificity, accuracy, precision, linearity, range, robustness.
- FDA, Analytical Procedures and Methods Validation for Drugs and Biologics, Guidance for Industry. The agency's own guidance on validating and documenting analytical procedures, cited for condition three.
- FDA / ICH Q6B, Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products. The framework in which identity, purity and quantity are separate tests with separate methods, which the claim-to-method table follows.
- FDA, Guidance for Industry: Pyrogen and Endotoxins Testing: Questions and Answers. Background for the endotoxin row of the table, including the LAL-based methods and their alternatives.